Diagnos Inc. (ADK.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 310 | 395 | 491 | 118 | 89 |
| Marketable Securities | 1,617 | 3,005 | 247 | 1,547 | 3,147 |
| Receivables | 195 | 120 | 93 | 153 | 152 |
| TOTAL | $2,200 | $3,688 | $923 | $1,912 | $3,466 |
| Non-Current Assets | |||||
| PPE Net | 190 | 216 | 249 | 141 | 170 |
| TOTAL | $190 | $216 | $249 | $141 | $170 |
| Total Assets | $2,391 | $3,904 | $1,172 | $2,053 | $3,636 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,072 | 1,481 | 1,943 | 2,154 | 2,691 |
| Accounts payable and accrued liabilities | 164 | 330 | 200 | 159 | 173 |
| Accrued Expenses | 138 | 191 | 122 | 199 | 158 |
| TOTAL | $1,478 | $2,110 | $2,374 | $2,606 | $3,117 |
| Non-Current Liabilities | |||||
| Long Term Debt | 139 | 186 | 194 | 197 | 202 |
| TOTAL | $226 | $298 | $335 | $248 | $286 |
| Total Liabilities | $1,704 | $2,408 | $2,710 | $2,855 | $3,403 |
| Shareholders' Equity | |||||
| Common Shares | 49,626 | 48,910 | 45,214 | 44,964 | 44,964 |
| Retained earnings | -59,489 | -58,304 | -57,143 | -56,047 | -54,933 |
| Other shareholders' equity | 10,549 | 10,890 | 10,391 | 10,281 | 10,202 |
| TOTAL | $687 | $1,496 | $-1,537 | $-802 | $233 |
| Total Liabilities And Equity | $2,391 | $3,904 | $1,172 | $2,053 | $3,636 |